Open Access

ARTICLE

Options and recent advances in permanent brachytherapy for prostate cancer

David T. Marshall

Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
Address correspondence to Dr. David Marshall, Department of Radiation Oncology, MUSC, 169 Ashley Avenue, Charleston, South Carolina 29425 USA

Canadian Journal of Urology 2007, 14(Suppl.6), 28-31.

Abstract

Permanent interstitial brachytherapy with I-125 or Pd- 103 seeds is a well-established approach as single modality for low-risk prostate cancer patients and as part of a multi-modality program for intermediate- and high-risk patients. There are multiple approaches that have been developed to deliver high-quality implants, including pre-planned and real-time intra-operative techniques. In the hands of experienced users, either approach can provide consistently excellent outcomes. We believe that the combination of real-time intra-operative dosimetry and connected seeds may provide for improved consistency due to decreased seed migration.

---

Keywords

---